Subscribe to RSS
DOI: 10.1055/s-0035-1546234
GABAA Receptor Binding Assays of Standardized Leonurus cardiaca and Leonurus japonicus Extracts as Well as Their Isolated Constituents[*]
Publication History
received 20 March 2015
revised 22 May 2015
accepted 25 May 2015
Publication Date:
28 July 2015 (online)
![](https://www.thieme-connect.de/media/plantamedica/20151213/lookinside/thumbnails/10-1055-s-0035-1546234_pmz0305-1.jpg)
Abstract
A main traditional use of European Leonurus cardiaca and East Asian Leonurus japonicus is in the treatment of neurological disorders such as anxiety, depression, nervousness, and as a sedative for insomnia. However, their mechanism of action is still under discussion. As anxiety and depressive disorders are increasingly being recognized as connected to dysfunctions of the gamma-aminobutyric acid system, the in vitro effects of standardized L. cardiaca and L japonicus extracts as well as five of their isolated constituents, namely, the labdane-type isoleosibirin, the novel iridoid 7R-chloro-6-desoxy-harpagide, the phenylethanoid lavandulifolioside, and the N-containing compounds stachydrine and leonurine, on this type of neuronal receptor were investigated for the first time. Extracts of L. cardiaca and L. japonicus, characterized by reversed-phase high-performance liquid chromatography determination, as well as their above named isolated, possible active constituents of different chemical nature were tested in several receptor binding assays at rat GABAA receptors using [3H]-SR95 531 and [3H]-Ro-15–1788 (flumazenil)/diazepam control. The L. cardiaca and L. japonicus extracts as well as leonurine inhibited the concentration-dependent binding of [3H]-SR95 531 to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor with a high binding affinity: IC50s 21 µg/ml, 46 µg/ml, and 15 µg/ml, respectively. In contrast, binding to the benzodiazepine site of the rat gamma-aminobutyric acid type A receptor had a 15 to 30 times lower binding affinity than to the gamma-aminobutyric acid site. The presented experiments provide hints that the neurological mechanism of action of L. cardiaca and L. japonicus may essentially be based on their interaction to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor, while the benzodiazepine site most probably does not contribute to this effect. In the case of L. japonicus, these effects can be at least partially explained by its leonurine constituent, whereas the active principle of L. cardiaca, which does not contain leonurine, is subject to further research as none of the other investigated individual constituents displayed significant activity in the applied test system.
Key words
Leonurus cardiaca - Leonurus japonicus - Lamiaceae - GABA - anxiolytic - sedative - leonurine* Dedicated to Prof. Dr. Drs. h. c. Adolf Nahrstedt, Münster, on the occasion of his 75th birthday. His earlier report [1] was an essential inspiration for the research project presented in the paper at hand.
-
References
- 1 Nahrstedt A. Drogen und Phytopharmaka mit sedierender Wirkung. Z Phytother 1985; 6: 101-109
- 2 Keller K. Assessment report on Leonurus cardiaca L., herba. EMA/HMPC/127430/2010/Community herbal monograph on Leonurus cardiaca L., herba. EMA/HMPC/127428/2010.
- 3 Li Shizhen. Bencao Gangmu (1593). Luo X, translator. Compendium of Materia Medica, Book III, Vol. 15, category of herbs (IV). Beijing: Foreign Languages Press; 2003: 1637-1644
- 4 Felter HW. The eclectic materia medica, pharmacology and therapeutics. Cincinnati: John K Scudder; 1922: 251-252
- 5 Kozo-Poljanskij BM. Motherwort – the new pharmaceutical and technical crop from the Voronezh region. Voronezh: House for the sanitary enlightenment of the Voronezh region; 1945: 1-10
- 6 Weiss RF. Lehrbuch der Phytotherapie. 2nd. edition. Stuttgart: Hippokrates; 1960: 213
- 7 Lombardi A. Leonurus cardiaca . Gazzetta Sanitaria 1947; No. 3
- 8 Orlandi E. Sullʼ applicazione del Leonorus cardiaca nella terapia infantile. Lattante 1950; 21: 582-586
- 9 Makarov VG, Aleksandrova AE, Shikov AN, Shiler LV, Ryzhenkov VE. Experimental and clinical study of preparation Iridol action on the central nervous system. Eksp Klin Farmakol 2006; 69: 23-25
- 10 Shikov AN, Pozharitskaya ON, Makarov VG, Demchenko DV, Shikh EV. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res 2011; 25: 540-543
- 11 Loh KP, Huang SH, Tan BK, Zhu YZ. Cerebral protection of purified Herba Leonuri extract on middle cerebral artery occluded rats. J Ethnopharmacology 2009; 125: 337-343
- 12 Rusch C, Hennig L, Rauwald HW. 7-Chloro-6-desoxy-harpagide, a major iridoid glucoside from Leonurus cardiaca L. (Ph.Eur.). Planta Med 2010; 76: 1252
- 13 Hennebelle T, Sahpaz S, Gressier B, Joseph H, Bailleul F. Antioxidant and neurosedative properties of polyphenols and iridoids from Lippia alba . Phytotherapy Research 2008; 22: 256-258
- 14 Kuchta K, Ortwein J, Hennig L, Rauwald HW. 1H-qNMR for direct quantification of stachydrine in Leonurus japonicus and L. cardiaca . Fitoterapia 2014; 96: 8-17
- 15 Qi J, Hong ZY, Xin H, Zhu YZ. Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex. Biol Pharm Bull 2010; 33: 1958-1964
- 16 Kuchta K, Ortwein J, Rauwald HW. Leonurus japonicus, Leonurus cardiaca, Leonotis leonurus: a novel HPLC study on the occurrence and content of the pharmacologically active guanidino derivative leonurine. Die Pharmazie 2012; 67: 973-979
- 17 Moon HI. Three diterpenes from Leonurus japonicus Houtt protect primary cultured rat cortical cells from glutamate-induced toxicity. Phytother Res 2010; 24: 1256-1259
- 18 Brückner A, Hennnig L, Rauwald HW. Leopersin E and further labdae-type diterpenes from Leonurus cardiaca L. Z Phytother 2012; S01: P07
- 19 Schramm A, Ebrahimi SN, Raith M, Zaugg J, Rueda DC, Hering S, Hamburger M. Phytochemical profiling of Curcuma kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABAA receptor modulators. Phytochemistry 2013; 96: 318-329
- 20 Zaugg J, Khom S, Eigenmann D, Baburin I, Hamburger M, Hering S. Identification and characterization of GABA(A) receptor modulatory diterpenes from Biota orientalis that decrease locomotor activity in mice. J Nat Prod 2011; 74: 1764-1772
- 21 He F, Lindqvist C, Harding WW. Leonurenones A–C: Labdane diterpenes from Leonotis leonurus . Phytochemistry 2012; 83: 168-172
- 22 Kuchta K, Ortwein J, Savtschenko A, Briel D, Volk RB, Rauwald HW. Leonurus cardiaca, L. japonicus, Leonotis leonurus: Quantitative HPLC and instrumental HPTLC determination of fourteen phenolics. Planta Med 2012; 78: PJ50
- 23 González-Correa JA, Navas MD, Lopez-Villodres JA, Trujillo M, Espartero JL, La Cruz De JP. Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci Lett 2008; 446: 143-146
- 24 Nötzel I. Leonurus cardiaca and defined phenolic constituents promote the hypothiocyanite producing activity of lactoperoxidase [diploma thesis]. Leipzig: Leipzig University; 2013
- 25 Wu YT, Lin LC, Sung JS, Tsai TH. Determination of acteoside in Cistanche deserticola and Boschniakia rossica and its pharmacokinetics in freely-moving rats using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 844: 89-95
- 26 DʼAngelo S, Manna C, Migliardi V, Mazzoni O, Morrica P, Capasso G, Pontoni G, Galletti P, Zappia V. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab Dispos 2001; 29: 1492-1498
- 27 Yaşar ŞN, Can ÖD, Öztürk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F. Central nervous system activities of Hypericum origanifolium extract via GABAergic and opioidergic mechanisms. Phytother Res 2013; 27: 877-884
- 28 Körfers A, Sun Y. Traditionelle Chinesische Medizin. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2009: 35
- 29 Kuchta K, Volk RB, Rauwald HW. Stachydrine in Leonurus cardiaca, Leonurus japonicus, Leonotis leonurus: detection and quantification by instrumental HPTLC and 1H-qNMR analyses. Pharmazie 2013; 68: 534-540
- 30 Ritter M, Melichar K, Strahler S, Kuchta K, Schulte J, Sartiani L, Cerbai E, Mugelli A, Mohr FW, Rauwald HW, Dhein S. Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. (Ph.Eur.). Planta Med 2010; 76: 572-582
- 31 Reuter G, Diehl HJ. Guanidinderivate in Leonurus sibiricus L. Pharmazie 1971; 26: 777
- 32 Nass R, Rimpler H. Distribution of iridoids in different populations of Physostegia virginia and some remarks on iridoids from Avicennia officinalis and Scrophularia ningpoensis . Phytochemistry 1996; 41: 489-498
- 33 Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005; 29: 1193-1205
- 34 Engin E, Treit D. The effects of intra-cerebral drug infusions on animalsʼ unconditioned fear reactions: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1399-1419
- 35 Ovanesov KB. The effect of tofisopam and tinctura leonuri on the color-discrimination function in young humans. Eksp Klin Farmakol 2005; 68: 56-59
- 36 Ovanesov KB, Ovanesova IM, Arushanian EB. Effects of melatonin and motherwort tincture on the emotional state and visual functions in anxious subjects. Eksp Klin Farmakol 2006; 69: 17-19
- 37 Rácz G, Rácz-Kotilla E. Sedative and antihypertensive activity of Leonurus quinquelobatus . Planta Med 1989; 55: 97
- 38 Sugaya K, Hashimoto F, Ono M, Ito Y, Masuoka C, Nohara T. Anti-oxidative constituents from Leonuri herba (Leonurus japonicus). Food Sci Technol Int Tokyo 1998; 4: 278-281
- 39 Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 2004; 98: 353-358
- 40 Wagner H, Jurcic K, Schaette R. Vergleichende Untersuchungen über die sedierende Wirkung von Baldrianextrakten, Valepotriaten und ihren Abbauprodukten. Planta Med 1980; 38: 358-365
- 41 Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol 1999; 51: 505-512
- 42 Mennini T, Bernasconi P, Bombardelli E, Morazzoni P. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 1993; 64: 291-300
- 43 Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U, Möhler H. GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 2009; 56: 174-181
- 44 Khom S, Baburin I, Timin E, Hohaus A, Trauner G, Kopp B, Hering S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology 2007; 53: 178-187
- 45 Trauner G, Khom S, Baburin I, Benedek B, Hering S, Kopp B. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta Med 2008; 74: 19-24
- 46 Kopp S, Baur R, Sigel E, Möhler H, Altmann KH. Highly potent modulation of GABA(A) receptors by valerenic acid derivatives. ChemMedChem 2010; 5: 678-681
- 47 Khom S, Strommer B, Ramharter J, Schwarz T, Schwarzer C, Erker T, Ecker GF, Mulzer J, Hering S. Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands – in vitro and in vivo characterization. Br J Pharmacol 2010; 161: 65-78
- 48 Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med 2008; 74: 1769-1773
- 49 Heaulme M, Chambon JP, Leyris R, Wermuth CG, Biziere K. C haracterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranes. J Neurochem 1987; 48: 1677-1686
- 50 Mehta AK, Shank RP. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15–4513 in the rat CNS. Brain Res 1995; 704: 289-297